Published - Fri, 11 Nov 2022

Gonorrhea: Clinical Features, Evaluation & Treatment

Gonorrhea: Clinical Features, Evaluation & Treatment

  • ETIOLOGY: Gonorrhea is caused by Neisseria gonorrhoeae.


Incidence: The ages of 20 and 24 have the highest frequency of the disease.


CLINICAL FEATURES

1. Local disease

a) Acute urethritis is the most common presentation in heterosexual men. Symptoms begin within 1 to 14 days of exposure and consist of dysuria and penile discharge. Three to ten percent of men with gonorrhea may be asymptomatic.

b) Cervicitis: Primary gonorrhea in women is usually asymptomatic, and when symptoms do occur, they are usually mild and non-specific. Up to 20% of women with primary gonorrhea develop pelvic inflammatory disease, and 33% to 81% of women with the pelvic inflammatory disease have gonorrhea.

c) Pharyngeal gonorrhea can be asymptomatic: The pharynx is colonized in 3% to 7% of heterosexual men, 5% to 20% of women, 10% to 25% of homosexual men, and 39% to 96% of pregnant women.

d) Anorectal gonorrhea is common in both heterosexual women and homosexual men and is often asymptomatic. When symptoms occur, they are usually mild pruritus and rectal discomfort.

2. Disseminated gonorrhea may complicate the disease course in 1% to 3% of patients with localized disease and is manifested most commonly as monoarticular arthritis or pustular dermatitis syndrome.


DIFFERENTIAL DIAGNOSES

1. Gonococcal urethritis must be differentiated from non-gonococcal urethritis caused by Chlamydia trachomatis.

2. Disseminated gonorrhea: N. meningitidis infection, acute rheumatic fever, and Reiter syndrome must be ruled out. Differential diagnoses for skin lesions include syphilis, HIV infection, and condyloma acuminata.


EVALUATION: Gram stain and culture of discharges are the cornerstones of diagnosis. All patients evaluated for gonorrhea should also have blood drawn for syphilis serology.


THERAPY: For uncomplicated cervicitis or urethritis:

1. Ceftriaxone (250 mg intramuscularly) and doxycycline (100 mg orally twice daily for 14 days, to cure possible concomitant Chlamydia infection) are the standard therapy.

2. Cefixime (400 mg orally in a single dose) is no longer an accepted alternative due to resistance.

3. Azithromycin, 2 g one-time dose, is an alternative for cephalosporin allergic patients.


DISPOSITION

1. Uncomplicated gonorrhea is managed on an outpatient basis. All sexual contacts must be identified and treated, and HIV testing should be considered by the patient with his or her primary physician at a later date.

2. Patients with disseminated gonorrhea require hospitalization.

Created by

Rigomo Team

Rigomo is a leading online education platform that offers a wide range of courses to help individuals enhance their skills and achieve their career goals. With our user-friendly interface and expert instructors, we strive to provide high-quality education to everyone, anytime and anywhere. Join us today and take the first step towards a brighter future.

Rigomo is an e-learning platform that was founded in 2019 by a team of dedicated professionals with a passion for revolutionizing the way people learn. The platform offers a range of online courses that cover various industries, including business, technology, healthcare, and more.

Rigomo's courses are designed to be interactive and engaging, with a focus on practical skills that learners can apply in their careers. The platform uses a combination of video lectures, quizzes, and hands-on projects to help learners master the subject matter.

Rigomo is committed to providing affordable and accessible education to people around the world. The platform offers a range of pricing options, including monthly and annual subscriptions, as well as pay-as-you-go options for individual courses.

Since its launch, Rigomo has received numerous accolades for its innovative approach to e-learning. The platform has helped thousands of learners across the globe acquire new skills and advance their careers.

As Rigomo continues to grow, the team remains committed to providing high-quality education that is accessible to all. The platform is constantly updating its courses and features to ensure that learners have access to the latest tools and technologies.

View profile

Comments (0)

Search
Popular categories
Latest blogs
25 Proven Strategies for Increasing Your Medical Practice's Patient Base
25 Proven Strategies for Increasing Your Medical Practice's Patient Base
1. Understand Your Audience2. Staff Training3. Patient Follow-Ups4. Mobile-Friendly Website5. Blogging6. Contests and Giveaways7. Online Reviews8. Community Involvement9. Social Media Savvy10. Monitor Online Reputation11. Embrace Technology12. Responsive Service13. Quality Service14. Flexible Scheduling15. Ask for Referrals16. Networking with Peers17. Email Reminders18. Email Marketing19. Local SEO20. Local Online Directories21. Media Exposure22. Real Images23. Re-engage Past Patients24. Emergency Availability25. Brochures and Business CardsConclusion

Fri, 19 Jan 2024

Disease X: A New Global Health Concern at Davos 2024
Disease X: A New Global Health Concern at Davos 2024
Imagine sitting at the prestigious World Economic Forum in Davos, Switzerland, with world leaders and health experts. They're all talking about something called "Disease X." It might sound like a sci-fi movie title, but it's a real concern, and it's making waves at Davos 2024.The Alarming PredictionThe World Health Organization (WHO) has raised the alarm that Disease X could be even deadlier than the COVID-19 pandemic we've been grappling with. They're warning that it might cause up to 20 times more deaths. That's a sobering thought, isn't it? So, what's the plan to deal with this potentially catastrophic scenario?Preparing for the UnknownOne of the sessions at Davos is titled "Preparation for Disease X." It features a lineup of heavy-hitters in the healthcare world, including the WHO's Director-General, Tedros Adhanom Ghebreyesus, and other influential figures like Preetha Reddy from Apollo Hospitals Enterprise Ltd. They're gathering to brainstorm and figure out how we can get ready for Disease X.Demystifying Disease XNow, you might be wondering, "What exactly is Disease X?" Well, it's not a specific disease like COVID-19 or Ebola. Instead, it's a term coined by the WHO to represent a hypothetical, unknown pathogen. Think of it as a placeholder for any new and unpredictable infectious agent that could spark a global epidemic. It's a reminder of how infectious diseases can come out of nowhere and catch us off guard.The Looming ThreatWhy all the fuss about Disease X? Well, it's not just a theoretical concern. Healthcare professionals in the UK issued a chilling warning recently, saying that Disease X could be as devastating as the 1918-1920 Spanish Flu, which claimed the lives of a staggering 50 million people worldwide. To put that in perspective, the COVID-19 pandemic, which we consider one of the worst in recent history, resulted in around 7 million global deaths.The WHO emphasizes that we need to be prepared for Disease X. There's a vast number of potential pathogens out there, and our resources for researching and developing treatments are limited. That's why leaders and experts are gathering at Davos – to figure out how to beef up our healthcare systems, foster global collaboration, and speed up research efforts.In a nutshell, Disease X is a big deal because it could be a game-changer, potentially worse than what we've seen with COVID-19. While it's still a hypothetical threat, it's a wake-up call. The discussions at Davos 2024 are a reminder that we need to be proactive in preparing for the unexpected. Strengthening our healthcare systems, working together globally, and ramping up research efforts are all part of the plan to face this ominous challenge head-on.

Wed, 17 Jan 2024

Dr. B. Jagadish: Transforming Healthcare Excellence with AI and IQAI
Dr. B. Jagadish: Transforming Healthcare Excellence with AI and IQAI
In the realm of healthcare, few individuals shine as brightly as Dr. B. Jagadish. A distinguished diabetologist and preventive cardiologist, he stands at the helm of MASTERDOCTOR Wellness Group of Clinics, a renowned healthcare establishment in Bhubaneswar, Odisha. Dr. Jagadish's journey is a testament to his unwavering commitment to medical excellence, innovation, and holistic wellness, with a special emphasis on harnessing the power of AI, including IQAI.A Lifelong Learner Dr. Jagadish's quest for knowledge is insatiable. He continually explores traditional knowledge bases and studies multiple therapeutic models to address chronic disorders like diabetes, hypertension, thyroid disorders, cardiovascular diseases, obesity, fatty liver, Alzheimer's, and Parkinson's. His keenness to embrace newer technologies, such as AI, automation, and ChatGPT prompt engineering, sets him apart in the healthcare landscape.A Visionary Researcher and Innovator Dr. Jagadish's innovative spirit extends to the formulation of patent neo ayurvedic herbal food supplements. These supplements have been integral to his clinical practice for over 12 years, offering effective holistic solutions to his patients.Join the Wellness Journey Dr. B. Jagadish's commitment to healthcare excellence, innovation, and holistic well-being is a beacon of hope and inspiration, with a profound reliance on the transformative power of AI, including IQAI. To learn more about his groundbreaking work and insights, visit his website at www.masterdoctorclinic.com or follow him on social media at @MasterdoctorWellness. Don't miss the opportunity to sign up for his newsletter, where regular updates and valuable tips on managing diabetes better await.#DrBJagadish #HealthcareExcellence #AIInnovation #HolisticWellness #DiabetesManagement #MasterdoctorWellness #IQAI

Mon, 15 Jan 2024

All blogs